AI & ChatGPT searches , social queries for EG 018

AI searches containing EG 018

EG 018

• EG-018

Chemical compound

inducing a signaling response. EG-018 is a controlled substance in Japan. BIM-018 CHM-018 JWH-018 THJ-018 FUB-018 NMP-7 "EG 018". www.caymanchem.com. Mogler

EG-018



EG-018

• JWH-018

Chemical compound

JWH-018, also known as 1-pentyl-3-(1-naphthoyl)indole, NA-PIMO, or AM-678, is a cannabinoid from the naphthoylindole family that acts as a full agonist

JWH-018



JWH-018

• EG-2201

Chemical compound

drug and is structurally related to other synthetic cannabinoids, such as EG-018 and MDMB-CHMCZCA. It is primarily used illicitly due to its psychoactive

EG-2201



EG-2201

• Δ8-Tetrahydrocannabinol

Isomer of tetrahydrocannabinol

hippocampus section of the brain. Furthermore, the synthetic cannabinoid EG-018 acts as a partial agonist. The classical cannabinoid structure is that of

Δ8-Tetrahydrocannabinol



Δ8-Tetrahydrocannabinol

• THJ-018

Chemical compound

THJ-018 (SGT-17) is a synthetic cannabinoid that is the indazole analogue of JWH-018 and has been sold online as a designer drug. THJ-018 acts as a full

THJ-018



THJ-018

• Conversion of CBD to THC

Synthesis of THC from CBD

CUMYL-4CN-B7AICA CUMYL-CB-MEGACLONE CUMYL-CH-MEGACLONE CUMYL-PEGACLONE EG-018 GSK-554,418A GW-842,166X JTE 7-31 LASSBio-881 LBP-1 Leelamine MDA-19 MDA-7

Conversion of CBD to THC

Conversion_of_CBD_to_THC

• Synthetic cannabinoids

Designer drugs

that affects the functions of the body, and the legality of JWH-018 is under review. JWH-018, CP 47,497 and the C6, C8, and C9 homologues of CP 47,497 have

Synthetic cannabinoids



Synthetic_cannabinoids

• Cannabis (drug)

Psychoactive drug from the cannabis plant

Journal of Neuroimmune Pharmacology. 13 (4): 438–52. doi:10.1007/s11481-018-9782-9. PMC 6223748. PMID 29556883. Colizzi M, McGuire P, Pertwee RG, Bhattacharyya

Cannabis (drug)



Cannabis_(drug)

• Hexahydrocannabiphorol

Semi-sythetic cannabinoid drug

CUMYL-4CN-B7AICA CUMYL-CB-MEGACLONE CUMYL-CH-MEGACLONE CUMYL-PEGACLONE EG-018 GSK-554,418A GW-842,166X JTE 7-31 LASSBio-881 LBP-1 Leelamine MDA-19 MDA-7

Hexahydrocannabiphorol



Hexahydrocannabiphorol

• List of designer drugs

5F-MDA-19 5F-PCN, 5F-MN-21 A-836,339 AB-CHFUPYCA BAY 38-7271 BIM-018 CB-13 EG-018 EG-2201 FUBIMINA, BIM-2201, BZ-2201, FTHJ JTE-907 JTE 7-31 LY-2183240

List of designer drugs



List_of_designer_drugs

• AM-2201

Chemical compound

potency of JWH-018 in rats, suggesting potent cannabinoid-like activity. AM-2201 metabolism differs only slightly from that of JWH-018. AM-2201 N-dealkylation

AM-2201



AM-2201

• Cannabidiol

Phytocannabinoid discovered in 1940

CUMYL-4CN-B7AICA CUMYL-CB-MEGACLONE CUMYL-CH-MEGACLONE CUMYL-PEGACLONE EG-018 GSK-554,418A GW-842,166X JTE 7-31 LASSBio-881 LBP-1 Leelamine MDA-19 MDA-7

Cannabidiol



Cannabidiol

• Tetrahydrocannabiphorol

Cannabinoid agonist compound

CUMYL-4CN-B7AICA CUMYL-CB-MEGACLONE CUMYL-CH-MEGACLONE CUMYL-PEGACLONE EG-018 GSK-554,418A GW-842,166X JTE 7-31 LASSBio-881 LBP-1 Leelamine MDA-19 MDA-7

Tetrahydrocannabiphorol



Tetrahydrocannabiphorol

• ADB-BUTINACA

Chemical compound

CUMYL-4CN-B7AICA CUMYL-CB-MEGACLONE CUMYL-CH-MEGACLONE CUMYL-PEGACLONE EG-018 GSK-554,418A GW-842,166X JTE 7-31 LASSBio-881 LBP-1 Leelamine MDA-19 MDA-7

ADB-BUTINACA



ADB-BUTINACA

• Effects of cannabis

of cannabis use when smoked depends on the potency, method of smoking – e.g. whether pure or in conjunction with tobacco – and quantity. Peak levels

Effects of cannabis



Effects_of_cannabis

• Tetrahydrocannabivarin

Homologue of tetrahydrocannabinol

CUMYL-4CN-B7AICA CUMYL-CB-MEGACLONE CUMYL-CH-MEGACLONE CUMYL-PEGACLONE EG-018 GSK-554,418A GW-842,166X JTE 7-31 LASSBio-881 LBP-1 Leelamine MDA-19 MDA-7

Tetrahydrocannabivarin



Tetrahydrocannabivarin

• Tetrahydrocannabinol

Psychoactive component of cannabis

including product matrix, ignition temperature, and inhalational dynamics (e.g., number, duration, and intervals of inhalations, breath hold time, depth

Tetrahydrocannabinol



Tetrahydrocannabinol

• Anandamide

Chemical compound (fatty acid neurotransmitter)

bliss?". Acta Pharmacologica Sinica. 40 (3): 309–323. doi:10.1038/s41401-018-0075-x. PMC 6460372. PMID 30050084. Pacher P, Bátkai S, Kunos G (September

Anandamide



Anandamide

• Cannabinoid

Compounds found in cannabis

Biological Psychiatry. 79 (7): 604–612. doi:10.1016/j.biopsych.2015.11.018. PMID 26852073. S2CID 24160677. Berida TI, Adekunle YA, Dada-Adegbola H,

Cannabinoid



Cannabinoid

• MDMB-4en-PINACA

Chemical compound

activated β-arrestin 2 recruitment) than JWH-018 (25.3 nM, 100%) with over 10x the binding affinity than JWH-018 in vitro. In a review of in vitro MDMB-4en-PINACA

MDMB-4en-PINACA



MDMB-4en-PINACA

• 10-Hydroxy-HHCP

Pharmaceutical compound

CUMYL-4CN-B7AICA CUMYL-CB-MEGACLONE CUMYL-CH-MEGACLONE CUMYL-PEGACLONE EG-018 GSK-554,418A GW-842,166X JTE 7-31 LASSBio-881 LBP-1 Leelamine MDA-19 MDA-7

10-Hydroxy-HHCP



10-Hydroxy-HHCP

• Rimonabant

Chemical compound

CUMYL-4CN-B7AICA CUMYL-CB-MEGACLONE CUMYL-CH-MEGACLONE CUMYL-PEGACLONE EG-018 GSK-554,418A GW-842,166X JTE 7-31 LASSBio-881 LBP-1 Leelamine MDA-19 MDA-7

Rimonabant



Rimonabant

• Tetrahydrocannabinolic acid

THC precursor

CUMYL-4CN-B7AICA CUMYL-CB-MEGACLONE CUMYL-CH-MEGACLONE CUMYL-PEGACLONE EG-018 GSK-554,418A GW-842,166X JTE 7-31 LASSBio-881 LBP-1 Leelamine MDA-19 MDA-7

Tetrahydrocannabinolic acid



Tetrahydrocannabinolic_acid

• 5F-ADB

Chemical compound

CUMYL-4CN-B7AICA CUMYL-CB-MEGACLONE CUMYL-CH-MEGACLONE CUMYL-PEGACLONE EG-018 GSK-554,418A GW-842,166X JTE 7-31 LASSBio-881 LBP-1 Leelamine MDA-19 MDA-7

5F-ADB



5F-ADB

• 10-Hydroxyhexahydrocannabinol

Pharmaceutical compound

CUMYL-4CN-B7AICA CUMYL-CB-MEGACLONE CUMYL-CH-MEGACLONE CUMYL-PEGACLONE EG-018 GSK-554,418A GW-842,166X JTE 7-31 LASSBio-881 LBP-1 Leelamine MDA-19 MDA-7

10-Hydroxyhexahydrocannabinol



10-Hydroxyhexahydrocannabinol

• THC-O-acetate

Acetate ester of tetrahydrocannabinol (THC)

CUMYL-4CN-B7AICA CUMYL-CB-MEGACLONE CUMYL-CH-MEGACLONE CUMYL-PEGACLONE EG-018 GSK-554,418A GW-842,166X JTE 7-31 LASSBio-881 LBP-1 Leelamine MDA-19 MDA-7

THC-O-acetate



THC-O-acetate

• Cannabichromene

Chemical compound

CUMYL-4CN-B7AICA CUMYL-CB-MEGACLONE CUMYL-CH-MEGACLONE CUMYL-PEGACLONE EG-018 GSK-554,418A GW-842,166X JTE 7-31 LASSBio-881 LBP-1 Leelamine MDA-19 MDA-7

Cannabichromene



Cannabichromene

• 11-Nor-9-carboxy-THC

Main secondary metabolite of THC

CUMYL-4CN-B7AICA CUMYL-CB-MEGACLONE CUMYL-CH-MEGACLONE CUMYL-PEGACLONE EG-018 GSK-554,418A GW-842,166X JTE 7-31 LASSBio-881 LBP-1 Leelamine MDA-19 MDA-7

11-Nor-9-carboxy-THC



11-Nor-9-carboxy-THC

• Entourage effect

Proposed mechanism of cannabis compounds

identified as "indica" or "sativa" based on common methods of differentiation (e.g. plant height or leaf shape) are not, in fact, chemically distinguishable

Entourage effect

Entourage_effect

• FUB-JWH-018

Chemical compound

FUB-JWH-018 (also known as FUB-018) is a naphthoylindole-based synthetic cannabinoid, representing a molecular hybrid of JWH-018 and AB-FUBICA or ADB-FUBICA

FUB-JWH-018



FUB-JWH-018

• Nabilone

Synthetic cannabinoid

Current Neurology and Neuroscience Reports. 18 (2): 8. doi:10.1007/s11910-018-0814-x. hdl:2123/18910. PMID 29442178. S2CID 3375801. "Nabilone Summary of

Nabilone



Nabilone

• MDMB-BINACA

Chemical compound

CUMYL-4CN-B7AICA CUMYL-CB-MEGACLONE CUMYL-CH-MEGACLONE CUMYL-PEGACLONE EG-018 GSK-554,418A GW-842,166X JTE 7-31 LASSBio-881 LBP-1 Leelamine MDA-19 MDA-7

MDMB-BINACA



MDMB-BINACA

• HHCP-O-acetate

Semi-synthetic cannabinoid derivative drug

CUMYL-4CN-B7AICA CUMYL-CB-MEGACLONE CUMYL-CH-MEGACLONE CUMYL-PEGACLONE EG-018 GSK-554,418A GW-842,166X JTE 7-31 LASSBio-881 LBP-1 Leelamine MDA-19 MDA-7

HHCP-O-acetate



HHCP-O-acetate

• 11-Hydroxy-THC

Active metabolite of Δ9-THC

CUMYL-4CN-B7AICA CUMYL-CB-MEGACLONE CUMYL-CH-MEGACLONE CUMYL-PEGACLONE EG-018 GSK-554,418A GW-842,166X JTE 7-31 LASSBio-881 LBP-1 Leelamine MDA-19 MDA-7

11-Hydroxy-THC



11-Hydroxy-THC

• Hexahydrocannabivarin

Chemical compound

CUMYL-4CN-B7AICA CUMYL-CB-MEGACLONE CUMYL-CH-MEGACLONE CUMYL-PEGACLONE EG-018 GSK-554,418A GW-842,166X JTE 7-31 LASSBio-881 LBP-1 Leelamine MDA-19 MDA-7

Hexahydrocannabivarin



Hexahydrocannabivarin

• THQ-PINACA

Chemical compound

as a designer drug, first identified in Slovenia in 2021. JWH-018 Org 28611 PB-22 THJ-018 ANALYTICAL REPORT THQ-PINACA (C22H25N3O) 1‐(1‐pentyl‐1H‐indazole‐3‐carbonyl)‐1

THQ-PINACA



THQ-PINACA

• Isotetrahydrocannabinol

Phytocannabinoid compound

CUMYL-4CN-B7AICA CUMYL-CB-MEGACLONE CUMYL-CH-MEGACLONE CUMYL-PEGACLONE EG-018 GSK-554,418A GW-842,166X JTE 7-31 LASSBio-881 LBP-1 Leelamine MDA-19 MDA-7

Isotetrahydrocannabinol



Isotetrahydrocannabinol

• Cis-THC

Cis enantiomer of tetrahydrocannabidiol

CUMYL-4CN-B7AICA CUMYL-CB-MEGACLONE CUMYL-CH-MEGACLONE CUMYL-PEGACLONE EG-018 GSK-554,418A GW-842,166X JTE 7-31 LASSBio-881 LBP-1 Leelamine MDA-19 MDA-7

Cis-THC



Cis-THC

• Dronabinol/palmidrol

Pharmaceutical compound

CUMYL-4CN-B7AICA CUMYL-CB-MEGACLONE CUMYL-CH-MEGACLONE CUMYL-PEGACLONE EG-018 GSK-554,418A GW-842,166X JTE 7-31 LASSBio-881 LBP-1 Leelamine MDA-19 MDA-7

Dronabinol/palmidrol



Dronabinol/palmidrol

• Z8526711350

Pharmaceutical compound

CUMYL-4CN-B7AICA CUMYL-CB-MEGACLONE CUMYL-CH-MEGACLONE CUMYL-PEGACLONE EG-018 GSK-554,418A GW-842,166X JTE 7-31 LASSBio-881 LBP-1 Leelamine MDA-19 MDA-7

Z8526711350



Z8526711350

• Δ11-Tetrahydrocannabinol

Isomer of tetrahydrocannabinol

CUMYL-4CN-B7AICA CUMYL-CB-MEGACLONE CUMYL-CH-MEGACLONE CUMYL-PEGACLONE EG-018 GSK-554,418A GW-842,166X JTE 7-31 LASSBio-881 LBP-1 Leelamine MDA-19 MDA-7

Δ11-Tetrahydrocannabinol



Δ11-Tetrahydrocannabinol

• ADB-5'Br-BUTINACA

Chemical compound

CUMYL-4CN-B7AICA CUMYL-CB-MEGACLONE CUMYL-CH-MEGACLONE CUMYL-PEGACLONE EG-018 GSK-554,418A GW-842,166X JTE 7-31 LASSBio-881 LBP-1 Leelamine MDA-19 MDA-7

ADB-5'Br-BUTINACA



ADB-5'Br-BUTINACA

• Tetrahydrocannabinol/cannabinol/cannabidiol

Pharmaceutical compound

CUMYL-4CN-B7AICA CUMYL-CB-MEGACLONE CUMYL-CH-MEGACLONE CUMYL-PEGACLONE EG-018 GSK-554,418A GW-842,166X JTE 7-31 LASSBio-881 LBP-1 Leelamine MDA-19 MDA-7

Tetrahydrocannabinol/cannabinol/cannabidiol



Tetrahydrocannabinol/cannabinol/cannabidiol

• THCP-O-acetate

Chemical compound

CUMYL-4CN-B7AICA CUMYL-CB-MEGACLONE CUMYL-CH-MEGACLONE CUMYL-PEGACLONE EG-018 GSK-554,418A GW-842,166X JTE 7-31 LASSBio-881 LBP-1 Leelamine MDA-19 MDA-7

THCP-O-acetate



THCP-O-acetate

• Caryophyllene

Natural bicyclic sesquiterpene

CUMYL-4CN-B7AICA CUMYL-CB-MEGACLONE CUMYL-CH-MEGACLONE CUMYL-PEGACLONE EG-018 GSK-554,418A GW-842,166X JTE 7-31 LASSBio-881 LBP-1 Leelamine MDA-19 MDA-7

Caryophyllene



Caryophyllene

• Δ10-Tetrahydrocannabinol

Isomer of tetrahydrocannabinol

CUMYL-4CN-B7AICA CUMYL-CB-MEGACLONE CUMYL-CH-MEGACLONE CUMYL-PEGACLONE EG-018 GSK-554,418A GW-842,166X JTE 7-31 LASSBio-881 LBP-1 Leelamine MDA-19 MDA-7

Δ10-Tetrahydrocannabinol



Δ10-Tetrahydrocannabinol

• 10-Hydroxy-THC

Pharmaceutical compound

CUMYL-4CN-B7AICA CUMYL-CB-MEGACLONE CUMYL-CH-MEGACLONE CUMYL-PEGACLONE EG-018 GSK-554,418A GW-842,166X JTE 7-31 LASSBio-881 LBP-1 Leelamine MDA-19 MDA-7

10-Hydroxy-THC



10-Hydroxy-THC

• HU-210

Synthetic cannabinoid

CUMYL-4CN-B7AICA CUMYL-CB-MEGACLONE CUMYL-CH-MEGACLONE CUMYL-PEGACLONE EG-018 GSK-554,418A GW-842,166X JTE 7-31 LASSBio-881 LBP-1 Leelamine MDA-19 MDA-7

HU-210



HU-210

• Tetrahydrocannabutol

Chemical compound

CUMYL-4CN-B7AICA CUMYL-CB-MEGACLONE CUMYL-CH-MEGACLONE CUMYL-PEGACLONE EG-018 GSK-554,418A GW-842,166X JTE 7-31 LASSBio-881 LBP-1 Leelamine MDA-19 MDA-7

Tetrahydrocannabutol



Tetrahydrocannabutol

• HHC-acetate

Semi-synthetic cannabinoid drug

CUMYL-4CN-B7AICA CUMYL-CB-MEGACLONE CUMYL-CH-MEGACLONE CUMYL-PEGACLONE EG-018 GSK-554,418A GW-842,166X JTE 7-31 LASSBio-881 LBP-1 Leelamine MDA-19 MDA-7

HHC-acetate



HHC-acetate

• Cannabinol

Naturally-occurring cannabinoid

have been shown to decrease production of immune-related chemical signals (e.g., cytokines) or undergo apoptosis as a consequence of CB2 agonism by CBN

Cannabinol



Cannabinol

• AM404

Active metabolite of paracetamol

CUMYL-4CN-B7AICA CUMYL-CB-MEGACLONE CUMYL-CH-MEGACLONE CUMYL-PEGACLONE EG-018 GSK-554,418A GW-842,166X JTE 7-31 LASSBio-881 LBP-1 Leelamine MDA-19 MDA-7

AM404



AM404

• List of cannabinoids

Arachidonoyl serotonin ACEA ACPA Arvanil AZ-11713908 BAY 38-7271 BAY 59-3074 BIM-018 Biochanin A BML-190 Nabidrox (Canbisol) Cannabicyclohexanol Cannabipiperidiethanone

List of cannabinoids



List_of_cannabinoids

• Cannabidiorcol

Phytocannabinoid

CUMYL-4CN-B7AICA CUMYL-CB-MEGACLONE CUMYL-CH-MEGACLONE CUMYL-PEGACLONE EG-018 GSK-554,418A GW-842,166X JTE 7-31 LASSBio-881 LBP-1 Leelamine MDA-19 MDA-7

Cannabidiorcol



Cannabidiorcol

• Irafamdastat

Pharmaceutical compound

CUMYL-4CN-B7AICA CUMYL-CB-MEGACLONE CUMYL-CH-MEGACLONE CUMYL-PEGACLONE EG-018 GSK-554,418A GW-842,166X JTE 7-31 LASSBio-881 LBP-1 Leelamine MDA-19 MDA-7

Irafamdastat

Irafamdastat

• 8,9-Dihydrocannabidiol

Chemical compound

CUMYL-4CN-B7AICA CUMYL-CB-MEGACLONE CUMYL-CH-MEGACLONE CUMYL-PEGACLONE EG-018 GSK-554,418A GW-842,166X JTE 7-31 LASSBio-881 LBP-1 Leelamine MDA-19 MDA-7

8,9-Dihydrocannabidiol



8,9-Dihydrocannabidiol

• MDMB-5'Br-BUTINACA

Chemical compound

CUMYL-4CN-B7AICA CUMYL-CB-MEGACLONE CUMYL-CH-MEGACLONE CUMYL-PEGACLONE EG-018 GSK-554,418A GW-842,166X JTE 7-31 LASSBio-881 LBP-1 Leelamine MDA-19 MDA-7

MDMB-5'Br-BUTINACA



MDMB-5'Br-BUTINACA

• Elcubragistat

Pharmaceutical compound

CUMYL-4CN-B7AICA CUMYL-CB-MEGACLONE CUMYL-CH-MEGACLONE CUMYL-PEGACLONE EG-018 GSK-554,418A GW-842,166X JTE 7-31 LASSBio-881 LBP-1 Leelamine MDA-19 MDA-7

Elcubragistat



Elcubragistat

• Hexahydrocannabihexol

Semi-synthetic cannabinoid derivative drug

CUMYL-4CN-B7AICA CUMYL-CB-MEGACLONE CUMYL-CH-MEGACLONE CUMYL-PEGACLONE EG-018 GSK-554,418A GW-842,166X JTE 7-31 LASSBio-881 LBP-1 Leelamine MDA-19 MDA-7

Hexahydrocannabihexol



Hexahydrocannabihexol

• Long-term effects of cannabis

Journal of Neuroimmune Pharmacology. 13 (4): 438–452. doi:10.1007/s11481-018-9782-9. PMC 6223748. PMID 29556883. Wenger T, Moldrich G, Furst S (July 2003)

Long-term effects of cannabis



Long-term_effects_of_cannabis

• Cannabiripsol

Chemical compound

9-Hydroxyhexahydrocannabinol 8,11-Dihydroxytetrahydrocannabinol Cannabitriol Boeren EG, Elsohly MA, Turner CE (October 1979). "Cannabiripsol: a novel Cannabis constituent"

Cannabiripsol



Cannabiripsol

• Vicasinabin

Pharmaceutical compound

CUMYL-4CN-B7AICA CUMYL-CB-MEGACLONE CUMYL-CH-MEGACLONE CUMYL-PEGACLONE EG-018 GSK-554,418A GW-842,166X JTE 7-31 LASSBio-881 LBP-1 Leelamine MDA-19 MDA-7

Vicasinabin



Vicasinabin

• Oleamide

Chemical compound

CUMYL-4CN-B7AICA CUMYL-CB-MEGACLONE CUMYL-CH-MEGACLONE CUMYL-PEGACLONE EG-018 GSK-554,418A GW-842,166X JTE 7-31 LASSBio-881 LBP-1 Leelamine MDA-19 MDA-7

Oleamide



Oleamide

• 1,2-Didehydro-3-oxo-THCO

Synthetic cannabinoid

CUMYL-4CN-B7AICA CUMYL-CB-MEGACLONE CUMYL-CH-MEGACLONE CUMYL-PEGACLONE EG-018 GSK-554,418A GW-842,166X JTE 7-31 LASSBio-881 LBP-1 Leelamine MDA-19 MDA-7

1,2-Didehydro-3-oxo-THCO



1,2-Didehydro-3-oxo-THCO

• ADB-5'F-BUTINACA

Chemical compound

CUMYL-4CN-B7AICA CUMYL-CB-MEGACLONE CUMYL-CH-MEGACLONE CUMYL-PEGACLONE EG-018 GSK-554,418A GW-842,166X JTE 7-31 LASSBio-881 LBP-1 Leelamine MDA-19 MDA-7

ADB-5'F-BUTINACA



ADB-5'F-BUTINACA

• Delta-8-THCM

Pharmaceutical compound

CUMYL-4CN-B7AICA CUMYL-CB-MEGACLONE CUMYL-CH-MEGACLONE CUMYL-PEGACLONE EG-018 GSK-554,418A GW-842,166X JTE 7-31 LASSBio-881 LBP-1 Leelamine MDA-19 MDA-7

Delta-8-THCM



Delta-8-THCM

• KLS-13019

Chemical compound

Journal of Molecular Neuroscience. 66 (1): 121–134. doi:10.1007/s12031-018-1154-7. PMC 6150782. PMID 30109468. Brenneman DE, Kinney WA, Ward SJ (August

KLS-13019



KLS-13019

• CB-86

Pharmaceutical compound

CUMYL-4CN-B7AICA CUMYL-CB-MEGACLONE CUMYL-CH-MEGACLONE CUMYL-PEGACLONE EG-018 GSK-554,418A GW-842,166X JTE 7-31 LASSBio-881 LBP-1 Leelamine MDA-19 MDA-7

CB-86



CB-86

• Lixosicone

Chemical compound

CUMYL-4CN-B7AICA CUMYL-CB-MEGACLONE CUMYL-CH-MEGACLONE CUMYL-PEGACLONE EG-018 GSK-554,418A GW-842,166X JTE 7-31 LASSBio-881 LBP-1 Leelamine MDA-19 MDA-7

Lixosicone



Lixosicone

• 2-Arachidonoylglycerol

Chemical compound

CUMYL-4CN-B7AICA CUMYL-CB-MEGACLONE CUMYL-CH-MEGACLONE CUMYL-PEGACLONE EG-018 GSK-554,418A GW-842,166X JTE 7-31 LASSBio-881 LBP-1 Leelamine MDA-19 MDA-7

2-Arachidonoylglycerol



2-Arachidonoylglycerol

• ADMB-3TMS-PRINACA

Designer drug

CUMYL-4CN-B7AICA CUMYL-CB-MEGACLONE CUMYL-CH-MEGACLONE CUMYL-PEGACLONE EG-018 GSK-554,418A GW-842,166X JTE 7-31 LASSBio-881 LBP-1 Leelamine MDA-19 MDA-7

ADMB-3TMS-PRINACA



ADMB-3TMS-PRINACA

• AB-CHMINACA

Chemical compound

Forensic Science International. 265: 121–4. doi:10.1016/j.forsciint.2016.01.018. PMID 26890319. Drug Enforcement Administration, Department of Justice (January

AB-CHMINACA



AB-CHMINACA

• 5F-APINACA

Chemical compound

CUMYL-4CN-B7AICA CUMYL-CB-MEGACLONE CUMYL-CH-MEGACLONE CUMYL-PEGACLONE EG-018 GSK-554,418A GW-842,166X JTE 7-31 LASSBio-881 LBP-1 Leelamine MDA-19 MDA-7

5F-APINACA



5F-APINACA

• 11-Hydroxyhexahydrocannabinol

Chemical compound

CUMYL-4CN-B7AICA CUMYL-CB-MEGACLONE CUMYL-CH-MEGACLONE CUMYL-PEGACLONE EG-018 GSK-554,418A GW-842,166X JTE 7-31 LASSBio-881 LBP-1 Leelamine MDA-19 MDA-7

11-Hydroxyhexahydrocannabinol



11-Hydroxyhexahydrocannabinol

• CUMYL-3TMS-PRINACA

Chemical compound

CUMYL-4CN-B7AICA CUMYL-CB-MEGACLONE CUMYL-CH-MEGACLONE CUMYL-PEGACLONE EG-018 GSK-554,418A GW-842,166X JTE 7-31 LASSBio-881 LBP-1 Leelamine MDA-19 MDA-7

CUMYL-3TMS-PRINACA



CUMYL-3TMS-PRINACA

• VIP36

Pharmaceutical compound

CUMYL-4CN-B7AICA CUMYL-CB-MEGACLONE CUMYL-CH-MEGACLONE CUMYL-PEGACLONE EG-018 GSK-554,418A GW-842,166X JTE 7-31 LASSBio-881 LBP-1 Leelamine MDA-19 MDA-7

VIP36



VIP36

• HU-331

Chemical compound

CUMYL-4CN-B7AICA CUMYL-CB-MEGACLONE CUMYL-CH-MEGACLONE CUMYL-PEGACLONE EG-018 GSK-554,418A GW-842,166X JTE 7-31 LASSBio-881 LBP-1 Leelamine MDA-19 MDA-7

HU-331



HU-331

• WIN 55,212-2

Chemical compound

CUMYL-4CN-B7AICA CUMYL-CB-MEGACLONE CUMYL-CH-MEGACLONE CUMYL-PEGACLONE EG-018 GSK-554,418A GW-842,166X JTE 7-31 LASSBio-881 LBP-1 Leelamine MDA-19 MDA-7

WIN 55,212-2



WIN_55,212-2

• PSN-632,408

Chemical compound

CUMYL-4CN-B7AICA CUMYL-CB-MEGACLONE CUMYL-CH-MEGACLONE CUMYL-PEGACLONE EG-018 GSK-554,418A GW-842,166X JTE 7-31 LASSBio-881 LBP-1 Leelamine MDA-19 MDA-7

PSN-632,408



PSN-632,408

• BZO-CHMOXIZID

Chemical compound

CUMYL-4CN-B7AICA CUMYL-CB-MEGACLONE CUMYL-CH-MEGACLONE CUMYL-PEGACLONE EG-018 GSK-554,418A GW-842,166X JTE 7-31 LASSBio-881 LBP-1 Leelamine MDA-19 MDA-7

BZO-CHMOXIZID



BZO-CHMOXIZID

• BIA 10-2474

Chemical compound

inhibitors into clinical trials without experiencing such adverse events (e.g., respectively, MK-4409, PF-04457845, JNJ-42165279, SSR411298, and V158866

BIA 10-2474



BIA_10-2474

• Cannabisol

Pharmaceutical compound

CUMYL-4CN-B7AICA CUMYL-CB-MEGACLONE CUMYL-CH-MEGACLONE CUMYL-PEGACLONE EG-018 GSK-554,418A GW-842,166X JTE 7-31 LASSBio-881 LBP-1 Leelamine MDA-19 MDA-7

Cannabisol



Cannabisol

• AB-PINACA

Chemical compound

CUMYL-4CN-B7AICA CUMYL-CB-MEGACLONE CUMYL-CH-MEGACLONE CUMYL-PEGACLONE EG-018 GSK-554,418A GW-842,166X JTE 7-31 LASSBio-881 LBP-1 Leelamine MDA-19 MDA-7

AB-PINACA



AB-PINACA

• CP 42,096

Cannabinoid agonist drug

CUMYL-4CN-B7AICA CUMYL-CB-MEGACLONE CUMYL-CH-MEGACLONE CUMYL-PEGACLONE EG-018 GSK-554,418A GW-842,166X JTE 7-31 LASSBio-881 LBP-1 Leelamine MDA-19 MDA-7

CP 42,096



CP_42,096

• Machaeriol A

Chemical compound

CUMYL-4CN-B7AICA CUMYL-CB-MEGACLONE CUMYL-CH-MEGACLONE CUMYL-PEGACLONE EG-018 GSK-554,418A GW-842,166X JTE 7-31 LASSBio-881 LBP-1 Leelamine MDA-19 MDA-7

Machaeriol A



Machaeriol_A

• Dexanabinol

Chemical compound

CUMYL-4CN-B7AICA CUMYL-CB-MEGACLONE CUMYL-CH-MEGACLONE CUMYL-PEGACLONE EG-018 GSK-554,418A GW-842,166X JTE 7-31 LASSBio-881 LBP-1 Leelamine MDA-19 MDA-7

Dexanabinol



Dexanabinol

• Perrottetinene

Chemical compound

CUMYL-4CN-B7AICA CUMYL-CB-MEGACLONE CUMYL-CH-MEGACLONE CUMYL-PEGACLONE EG-018 GSK-554,418A GW-842,166X JTE 7-31 LASSBio-881 LBP-1 Leelamine MDA-19 MDA-7

Perrottetinene



Perrottetinene

• NMP-7

Chemical compound

potent analgesic effects in a variety of different tests. CUMYL-PEGACLONE EG-018 You H, Gadotti VM, Petrov RR, Zamponi GW, Diaz P (November 2011). "Functional

NMP-7



NMP-7

• 4'Cl-CUMYL-PINACA

Chemical compound

CUMYL-4CN-B7AICA CUMYL-CB-MEGACLONE CUMYL-CH-MEGACLONE CUMYL-PEGACLONE EG-018 GSK-554,418A GW-842,166X JTE 7-31 LASSBio-881 LBP-1 Leelamine MDA-19 MDA-7

4'Cl-CUMYL-PINACA



4'Cl-CUMYL-PINACA

• A-PONASA

Chemical compound

2022. Andrews R, Jorge R, Christie R, Gallegos A (April 2023). "From JWH-018 to OXIZIDS: Structural evolution of synthetic cannabinoids in the European

A-PONASA



A-PONASA

• Comparison of phytocannabinoids

CUMYL-4CN-B7AICA CUMYL-CB-MEGACLONE CUMYL-CH-MEGACLONE CUMYL-PEGACLONE EG-018 GSK-554,418A GW-842,166X JTE 7-31 LASSBio-881 LBP-1 Leelamine MDA-19 MDA-7

Comparison of phytocannabinoids

Comparison_of_phytocannabinoids

• NESS-040C5

Chemical compound

CUMYL-4CN-B7AICA CUMYL-CB-MEGACLONE CUMYL-CH-MEGACLONE CUMYL-PEGACLONE EG-018 GSK-554,418A GW-842,166X JTE 7-31 LASSBio-881 LBP-1 Leelamine MDA-19 MDA-7

NESS-040C5



NESS-040C5

• MDMB-CHMICA

Chemical compound

value of 0.14 nM, which is approximately 8 times lower than the EC50 of JWH-018 (1.13 nM) and twofold lower than AB-CHMINACA (0.27 nM). MDMB-CHMICA's main

MDMB-CHMICA



MDMB-CHMICA

• 2-Arachidonyl glyceryl ether

Chemical compound

CUMYL-4CN-B7AICA CUMYL-CB-MEGACLONE CUMYL-CH-MEGACLONE CUMYL-PEGACLONE EG-018 GSK-554,418A GW-842,166X JTE 7-31 LASSBio-881 LBP-1 Leelamine MDA-19 MDA-7

2-Arachidonyl glyceryl ether



2-Arachidonyl_glyceryl_ether

• MDMB-5'Br-4en-PINACA

Pharmaceutical compound

CUMYL-4CN-B7AICA CUMYL-CB-MEGACLONE CUMYL-CH-MEGACLONE CUMYL-PEGACLONE EG-018 GSK-554,418A GW-842,166X JTE 7-31 LASSBio-881 LBP-1 Leelamine MDA-19 MDA-7

MDMB-5'Br-4en-PINACA



MDMB-5'Br-4en-PINACA

• JWH-210

Chemical compound

CUMYL-4CN-B7AICA CUMYL-CB-MEGACLONE CUMYL-CH-MEGACLONE CUMYL-PEGACLONE EG-018 GSK-554,418A GW-842,166X JTE 7-31 LASSBio-881 LBP-1 Leelamine MDA-19 MDA-7

JWH-210



JWH-210

• CP 55,940

Chemical compound

CUMYL-4CN-B7AICA CUMYL-CB-MEGACLONE CUMYL-CH-MEGACLONE CUMYL-PEGACLONE EG-018 GSK-554,418A GW-842,166X JTE 7-31 LASSBio-881 LBP-1 Leelamine MDA-19 MDA-7

CP 55,940



CP_55,940

• Abeo-HHC acetate

Semi-synthetic derivative of THC

CUMYL-4CN-B7AICA CUMYL-CB-MEGACLONE CUMYL-CH-MEGACLONE CUMYL-PEGACLONE EG-018 GSK-554,418A GW-842,166X JTE 7-31 LASSBio-881 LBP-1 Leelamine MDA-19 MDA-7

Abeo-HHC acetate



Abeo-HHC_acetate

• Cannabidiolic acid

Chemical compound

CUMYL-4CN-B7AICA CUMYL-CB-MEGACLONE CUMYL-CH-MEGACLONE CUMYL-PEGACLONE EG-018 GSK-554,418A GW-842,166X JTE 7-31 LASSBio-881 LBP-1 Leelamine MDA-19 MDA-7

Cannabidiolic acid



Cannabidiolic_acid

• Arachidonylcyclopropylamide

Chemical compound

CUMYL-4CN-B7AICA CUMYL-CB-MEGACLONE CUMYL-CH-MEGACLONE CUMYL-PEGACLONE EG-018 GSK-554,418A GW-842,166X JTE 7-31 LASSBio-881 LBP-1 Leelamine MDA-19 MDA-7

Arachidonylcyclopropylamide



Arachidonylcyclopropylamide

AI & ChatGPT searchs for online references containing EG 018

EG 018

AI search references containing EG 018

EG 018

AI search queries for Facebook and twitter posts, hashtags with EG 018

EG 018

Follow users with usernames @EG 018 or posting hashtags containing #EG 018

EG 018

Online names & meanings

AI search & ChatGPT queries for Facebook and twitter users, user names, hashtags with EG 018

EG 018

Top AI & ChatGPT search, Social media, medium, facebook & news articles containing EG 018

EG 018

AI searchs for Acronyms & meanings containing EG 018

EG 018

Other words and meanings similar to

EG 018

AI search in online dictionary sources & meanings containing EG 018

EG 018